Investment
Features
FeesSafety
Academy
More
Pluang+

Binance Alpha launches Derive token airdrop with point-based claims and decreasing thresholds.

Protocol Fundamentals
14 Oct 2026
Tokenpost
View Source
Neutral
Binance Alpha launches Derive token airdrop with point-based claims and decreasing thresholds.

Binance Alpha has introduced the Derive (DRV) token airdrop, allowing users with at least 245 Binance Alpha points to claim tokens via the platform's event page. Each claim consumes 15 points, and tokens are distributed on a first-come, first-served basis. The points threshold to claim decreases by five every five minutes if the campaign remains open, encouraging quicker participation. This event offers users a chance to access a 70-token airdrop through active engagement on Binance Alpha.

The Binance Alpha Derive token airdrop event is the subject here, provided as market context. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 14, 2026 16:31 WIB: out of 50 major cryptocurrencies, 13 rose and 36 fell today. EGLD traded at Rp66.905 with a 3.09% decline and 100% buy orders, contrasting with FIL at Rp20.490 down 2.86% and a nearly balanced sell/buy split, while NEO stood at Rp42.207, down 2.81% with 100% buy orders.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App